This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
How does Harungana madagascariensis work for wound healing?
Harungana madagascariensis contains bioactive compounds including xanthones, anthraquinones, and tannins that contribute to its wound healing properties. The tannins provide astringent effects that help contract wound edges and reduce bleeding, while xanthones and flavonoids demonstrate antimicrobial activity against bacteria commonly found in skin infections. These compounds work synergistically to reduce inflammation and support tissue repair. Evidence level: C (preclinical and traditional use data).
Does Harungana madagascariensis interact with any medications?
Harungana madagascariensis may interact with hepatotoxic medications due to its potential to cause liver damage with prolonged use. Concurrent use with drugs metabolized by the liver, such as acetaminophen, statins, or certain antibiotics, may increase hepatotoxicity risk. The herb's traditional use for malaria suggests potential interactions with antimalarial drugs, though specific clinical interaction data is lacking. Patients taking prescription medications should consult a healthcare provider before use. Evidence level: C.
What is the recommended dosage for Harungana madagascariensis bark?
The traditional adult dosage for Harungana madagascariensis is a bark decoction of approximately 200ml taken twice daily. This preparation involves boiling the dried bark in water and straining before consumption. Dosage may vary depending on the specific condition being treated and should be guided by a qualified herbalist or healthcare provider. Internal use of the raw orange latex should be avoided due to safety concerns. Evidence level: Traditional/C.
Is Harungana madagascariensis safe during pregnancy?
Harungana madagascariensis is contraindicated during pregnancy and should be avoided. The plant contains anthraquinones and other bioactive compounds that may stimulate uterine contractions or cause harm to the developing fetus. Traditional use data and the presence of these constituents support this safety classification. Women who are pregnant, planning to become pregnant, or breastfeeding should not use this herb internally or externally without medical supervision. Evidence level: C/Traditional.
What is Harungana madagascariensis used for in traditional medicine?
Harungana madagascariensis has been used traditionally across sub-Saharan Africa for wound healing, skin infections, malaria, dysentery, and anemia. The orange latex and bark preparations are applied topically for wounds and skin conditions, while decoctions are taken internally for systemic complaints. The plant's antimicrobial and anti-inflammatory properties make it valuable in traditional healing practices throughout its native range. Evidence level: C (based on ethnobotanical studies and preclinical research).
What are the side effects of Harungana madagascariensis?
Harungana madagascariensis may cause skin irritation when applied topically, particularly with the raw latex. Prolonged internal use has been associated with hepatotoxicity (liver damage), making it unsuitable for individuals with pre-existing liver disease. Other potential side effects are not well documented due to limited clinical research. Users should monitor for signs of liver dysfunction including jaundice, fatigue, and abdominal pain, and discontinue use immediately if these occur. Evidence level: C/Traditional.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Harungana madagascariensis is a widespread African pioneer tree used in traditional medicine for microbial infections, malaria, and skin care [PMID:40693248, 26721224, 38486384].
Background
Harungana madagascariensis (Hypericaceae) is a dominant native pioneer tree species found in Africa, including the volcanic oceanic island of Mauritius [PMID:40421372, 41438116].
Traditional uses
In Cameroonian folk medicine, it is used to treat malaria, typhoid fever, and a wide range of human diseases including microbial infections [PMID:26721224, 40693248]. It is also traditionally used for skin care [PMID:38486384].
Active compounds
The plant contains prenylated anthranoids (e.g., kenganthranols A-M, harunganols A-I, harunmadagascarins A-D), anthraquinones, anthrones (e.g., madagascenone A and B, bazouanthrone), and flavanones such as astilbin [PMID:33711738, 26727375, 15924922, 16483735, 17329893, 26621758]. Other identified constituents include alkaloids, terpenoids, saponins, phenols, flavonoids, tannins, anthocyanins, betulinic acid, and lupeol [PMID:40693248, 15924922, 27267830].
Mechanism of action
A plant extract (HME) induces genes stimulated by retinol, including the upregulation of all RARs and RXRs (including RXRγ) [PMID:35238059]. Certain compounds exhibit α-glucosidase inhibitory activity [PMID:33711738, 26727375, 26621758, 16499321]. Other fractions regulate collagen and melanin biosynthesis gene expression (TYR, TRP-1, COL1A1, MMP-1) and inhibit 15-lipoxygenase and nitric oxide (NO) in macrophages [PMID:38486384].
Clinical evidence
Evidence BSkin Aging
A cosmetic cream containing H. madagascariensis extract (HME) showed anti-aging effects indistinguishable from a retinol cream regarding wrinkles under the eyes, ptosis, color homogeneity, smoothness, plumpness, firmness, and elasticity over 28 to 56 days [PMID:37155516]
Evidence DSalmonellosis (Typhoid Fever)
Aqueous leaf extract significantly reduced viable Salmonella Typhimurium in a rat model and could stop salmonellosis after 10 days of treatment [PMID:26721224]
Evidence DBacterial Infections
Leaf extracts demonstrate in vitro antibacterial activity against B. subtilis, S. aureus, E. coli, and S. typhi [PMID:11933123], and against oral bacteria implicated in dental caries and gingivitis [PMID:16809192].
Evidence DMalaria
Isolated compounds from root bark, specifically bazouanthrone, showed potency against Plasmodium falciparum in vitro [PMID:17329893].
Safety & adverse effects
In rats, intraperitoneal administration of isosaline leaf and stem-bark extracts (400 mg/kg) caused significant elevation of liver, kidney, and serum alanine and aspartate aminotransferase activities, as well as elevated serum urea, total proteins, triglycerides, and cholesterol [PMID:15305323]. High doses (≥100mg/kg) of aqueous leaf extract in rats showed biochemical and histological side effects [PMID:26721224].
Evidence summary
Evidence consists primarily of in vitro studies and animal models (Level D), with one preliminary clinical study on human subjects for cosmetic application (Level B).
PubMed sources
1.PMID: 33711738 (2021) — Further prenylated anthranoids from Harungana madagascariensis. · Phytochemistry
2.PMID: 35238059 (2022) — A Harungana madagascariensis extract with retinol-like properties: Gene upregulations and protein expressions in human fibroblasts and skin explants. · International journal of cosmetic science
3.PMID: 26727375 (2016) — α-Glucosidase Inhibitory Prenylated Anthranols from Harungana madagascariensis. · Journal of natural products
4.PMID: 40421372 (2025) — A scoping review of tropical pioneer trees' roles for restoration and conservation management: Harungana madagascariensis (Hypericaceae) a widespread African species as a model. · PeerJ
5.PMID: 41438116 (2025) — Harungana madagascariensis (Hypericaceae) is a key phorophyte for native epiphytes and lianas during ecological restoration: case study on an oceanic island.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 23663227 (2013) — Protective effects of stem bark of Harungana madgascariensis on the red blood cell membrane. · BMC complementary and alternative medicine
7.PMID: 37155516 (2023) — In a Preliminary Study on Human Subjects, a Cosmetic Cream Containing a Harungana madagascariensis Plant Extract Induces Similar Anti-Aging Effects to a Retinol-Containing Cream. · Clinical, cosmetic and investigational dermatology
8.PMID: 38486384 (2025) — Bioactive Fractions Isolated from Harungana madagascariensis Lam. and Psorospermum aurantiacum Engl. Regulate Collagen and Melanin Biosynthesis Gene Expression in UVB-irradiated Cells with Additional Anti-inflammatory Potential. · Current drug research reviews
9.PMID: 26721224 (2016) — Antityphoid properties and toxicity evaluation of Harungana madagascariensis Lam (Hypericaceae) aqueous leaf extract. · Journal of ethnopharmacology
10.PMID: 40693248 (2025) — Phytochemical Composition, Antibacterial Activity, Modes of Action, and Antibiotic Resistance-Modifying Effects of Harungana madagascariensis (Hypericaceae) Against Multidrug-Resistant Pseudomonas aeruginosa. · Scientifica
11.PMID: 11933123 (2002) — Antibacterial activity of Harungana madagascariensis leaf extracts. · Phytotherapy research : PTR
12.PMID: 25785542 (2015) — Nutrient Composition and In Vitro Antioxidant Properties of Harungana madagascariensis Stembark Extracts. · Journal of medicinal food
13.PMID: 18372133 (2008) — Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria. · Journal of ethnopharmacology
14.PMID: 28890153 (2017) — Medicinal plants for in vitro antiplasmodial activities: A systematic review of literature. · Parasitology international
15.PMID: 17352491 (2007) — Antimicrobial prenylated anthracene derivatives from the leaves of Harungana madagascariensis. · Journal of natural products
16.PMID: 33777157 (2021) — Parts, Period, and Extraction Solvents as Parameters Influencing Harungana madagascariensis Lam. ex Poir. (Hypericaceae) Antibacterial Activity. · Evidence-based complementary and alternative medicine : eCAM
17.PMID: 40773488 (2025) — Anti-staphylococcal activity, antibiotic-resistance modulation effects and action of Harungana madagascariensis (Hypericaceae) fruit extracts on the antioxidant system of multidrug-resistant Staphylococcus aureus. · PloS one
18.PMID: 15924922 (2005) — Prenylated anthronoid antioxidants from the stem bark of Harungana madagascariensis. · Phytochemistry
19.PMID: 41343431 (2025) — Correction: Anti-staphylococcal activity, antibiotic-resistance modulation effects and action of Harungana madagascariensis (Hypericaceae) fruit extracts on the antioxidant system of multidrug-resistant Staphylococcus aureus. · PloS one
20.PMID: 27267830 (2016) — Antibacterial activities of the methanol extracts, fractions and compounds from Harungana madagascariensis Lam. ex Poir. (Hypericaceae). · Journal of ethnopharmacology
21.PMID: 26621758 (2016) — New α-glucosidase inhibiting anthracenone from the barks of Harungana madagascariensis Lam. · Natural product research
22.PMID: 16483735 (2006) — Isolation and in vitro antibacterial activity of astilbin, the bioactive flavanone from the leaves of Harungana madagascariensis Lam. ex Poir. (Hypericaceae). · Journal of ethnopharmacology
23.PMID: 15305323 (2004) — Biochemical changes elicited by isosaline leaf and stem-bark extracts of Harungana madagascariensis in the rat. · Phytotherapy research : PTR
24.PMID: 16809192 (2006) — Potentiation of the bactericidal activity of Harungana madagascariensis Lam. ex Poir. (Hypericaceae) leaf extract against oral bacteria using poly (D, L-lactide-co-glycolide) nanoparticles: in vitro study. · Acta odontologica Scandinavica
25.PMID: 26258052 (2015) — Nanomedicines for dental applications-scope and future perspective. · International journal of pharmaceutical investigation
26.PMID: 16499321 (2006) — Alpha-glucosidase inhibitory anthranols, kenganthranols A-C, from the stem bark of Harungana madagascariensis. · Journal of natural products
27.PMID: 17329893 (2007) — Anti-plasmodial activity of some constituents of the root bark of Harungana madagascariensis LAM. (Hypericaceae). · Chemical & pharmaceutical bulletin
28.PMID: 17385560 (2007) — In vitro antimicrobial activity of the leaf extract of Harungana madagascariensis Lam. Ex Poir. (Hypericaceae) against strains causing otitis externa in dogs and cats. · Acta veterinaria Hungarica
29.PMID: 15125572 (2004) — Formation of particles in aqueous infusions of the medical plant Harungana madagascariensis. · Die Pharmazie
30.PMID: 19069532 (2007) — Medicinal plants can be good source of antioxidants: case study in Cameroon. · Pakistan journal of biological sciences : PJBS